276 related articles for article (PubMed ID: 16932717)
1. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
Elliott JR; Manzi S
Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
[No Abstract] [Full Text] [Related]
2. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for lupus nephritis.
McCune WJ
N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
5. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
Lau KK; Ault BH; Jones DP; Butani L
J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
Karassa FB; Isenberg DA
N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
[No Abstract] [Full Text] [Related]
7. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
[TBL] [Abstract][Full Text] [Related]
8. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
Killen JP
N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16482673
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
Karassa FB
N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16481648
[No Abstract] [Full Text] [Related]
12. [Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide].
Baños I; Yebra M; Fernández J; Ramón y Cajal S
Med Clin (Barc); 2003 Jun; 121(4):158. PubMed ID: 12867023
[No Abstract] [Full Text] [Related]
13. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
16. [Mycophenolate mofetil in lupus nephritis treatment].
Savio V; Alba P; Babini AM
Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
[No Abstract] [Full Text] [Related]
17. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
Tse KC; Tang CS; Lio WI; Lam MF; Chan TM
Lupus; 2006; 15(6):371-9. PubMed ID: 16830884
[TBL] [Abstract][Full Text] [Related]
18. What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?
Jones RB; Walsh M; Smith KG
Curr Opin Rheumatol; 2009 May; 21(3):256-61. PubMed ID: 19399995
[TBL] [Abstract][Full Text] [Related]
19. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?
Hogan J; Schwenk MH; Radhakrishnan J
Kidney Int; 2012 Dec; 82(12):1256-60. PubMed ID: 22648298
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
